Mode
Text Size
Log in / Sign up

Meta-analysis links postnatal BPA exposure to increased odds of early pubertal onset in children

Meta-analysis links postnatal BPA exposure to increased odds of early pubertal onset in children
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider observational link between postnatal BPA and early puberty in girls; evidence is limited and not causal.

This systematic review and meta-analysis examined the association between postnatal Bisphenol A (BPA) exposure and risk of precocious puberty or early pubertal onset in children. The analysis included 5,549 participants, predominantly girls, though the specific study settings and follow-up duration were not reported. The exposure was postnatal BPA exposure, compared against lower postnatal BPA exposure levels, with the primary outcome being early pubertal onset, including central precocious puberty.

The main analysis found that higher postnatal BPA exposure was observationally associated with increased odds of early pubertal onset, with a pooled odds ratio (OR) of 4.45 (95% CI: 1.69–11.72). Dose-response analyses, based on only three studies, suggested a 14% increase in odds per 1 μg/L increment in BPA exposure. Safety and tolerability data were not reported in the available evidence.

Key limitations include high statistical heterogeneity (I² = 92%), evidence in boys that was limited and inconclusive, and the inclusion of cross-sectional studies that cannot establish temporal relationships. The dose-response finding should be interpreted cautiously due to the small number of contributing studies. The practice relevance is primarily applicable to girls, as the findings should not be extrapolated to boys given the limited male data. The authors explicitly note these findings should not be interpreted as evidence of causality.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Precocious puberty (PP), defined as the development of secondary sexual characteristics before age eight in girls or nine in boys, has shown a rising prevalence globally. Bisphenol A (BPA), an endocrine-disrupting chemical commonly found in plastics, has been suggested to influence pubertal timing, but epidemiological evidence remains inconsistent. This systematic review and meta-analysis aimed to evaluate the association between postnatal BPA exposure and early pubertal onset in children. Following PRISMA 2020 guidelines, PubMed, Embase, Scopus, Web of Science, and Cochrane were searched for observational studies published between 2000 and 2024. Eligible studies assessed postnatal BPA exposure using validated analytical methods (e.g., LC–MS/MS) and reported associations with central precocious puberty (CPP) or related early pubertal outcomes. Risk of bias was evaluated using the Newcastle–Ottawa Scale, and random-effects meta-analysis was used to pool odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity, publication bias, and certainty of evidence were assessed via I2, Egger's test, and GRADE. Nine studies comprising 5,549 participants, predominantly girls were included, of which nine provided data for meta-analysis. Higher postnatal BPA exposure was observationally associated with increased odds of early pubertal onset (pooled OR = 4.45, 95% CI: 1.69–11.72), with a heterogeneity of (I2 = 92%).Associations were stronger among girls and in studies using LC–MS/MS. Dose–response analyses, based on three studies, suggested a 14% increase in odds per 1 μg/L BPA increment and should be interpreted cautiously. Evidence in boys was limited and inconclusive Postnatal BPA exposure shows a consistent observational association with early pubertal onset in girls. These findings should not be interpreted as evidence of causality. The results are primarily applicable to girls and should not be extrapolated to boys, given the limited male data. Cross-sectional studies provide supportive evidence only and do not establish temporal relationships.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.